Characteristics and applications of nucleic acid sequence-based amplification (NASBA)

被引:225
|
作者
Deiman, B [1 ]
van Aarle, P [1 ]
Sillekens, P [1 ]
机构
[1] Organon Teknika BV, NL-5281 RM Boxtel, Netherlands
关键词
NASBA; primer design; isolation; ECL; molecular beacon; RT-PCR;
D O I
10.1385/MB:20:2:163
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nucleic acid sequence-based amplification (NASBA) is a sensitive, isothermal, transcription-based amplification system specifically designed for the detection of RNA targets. In some NASBA systems, DNA is also amplified though very inefficiently and only in the absence of the corresponding RNA target or in case of an excess (>1000-fold) of target DNA over RNA. As NASBA is primer-dependent and amplicon detection is based on probe binding, primer and probe design rules are included. An overview of various target nucleic acids that have been amplified successfully using NASBA is presented. For the isolation of nucleic acids prior to NASBA, the "Boom" method, based on the denaturing properties of guanidine isothiocyanate and binding of nucleic acid to silica particles, is preferred. Currently, electro-chemiluminescence (ECL) is recommended for the detection of the amplicon at the end of amplification. In the near future, molecular beacons will be introduced enabling "real-time detection," i.e., amplicon detection during amplification. Quantitative HIV-1 NASBA and detection of up to 48 samples can then be performed in only 90 min.
引用
收藏
页码:163 / 179
页数:17
相关论文
共 50 条
  • [1] Characteristics and applications of nucleic acid sequence-based amplification (NASBA)
    Birgit Deiman
    Pierre van Aarle
    Peter Sillekens
    [J]. Molecular Biotechnology, 2002, 20 : 163 - 179
  • [2] NUCLEIC-ACID SEQUENCE-BASED AMPLIFICATION (NASBA) FOR THE IDENTIFICATION OF MYCOBACTERIA
    VANDERVLIET, GME
    SCHUKKINK, RAF
    VANGEMEN, B
    SCHEPERS, P
    KLATSER, PR
    [J]. JOURNAL OF GENERAL MICROBIOLOGY, 1993, 139 : 2423 - 2429
  • [3] Novel application for isothermal nucleic acid sequence-based amplification (NASBA)
    Boehmer, Anne
    Schildgen, Verena
    Luesebrink, Jessica
    Ziegler, Susanne
    Tillmann, Ramona L.
    Kleines, Michael
    Schildgen, Oliver
    [J]. JOURNAL OF VIROLOGICAL METHODS, 2009, 158 (1-2) : 199 - 201
  • [4] NUCLEIC ACID SEQUENCE BASED AMPLIFICATION (NASBA)-PROSPECTS AND APPLICATIONS
    Fakruddin, Md.
    Mazumdar, Reaz Mohammad
    Chowdhury, Abhijit
    Bin Mannan, Khanjada Shahnewaj
    [J]. INTERNATIONAL JOURNAL OF LIFE SCIENCE AND PHARMA RESEARCH, 2012, 2 (01): : L106 - L121
  • [5] Nucleic acid sequence-based amplification (NASBA) in molecular bacteriology: A procedural guide
    Gracias, Kiev S.
    McKillip, John L.
    [J]. JOURNAL OF RAPID METHODS AND AUTOMATION IN MICROBIOLOGY, 2007, 15 (03): : 295 - 309
  • [6] Detection of animal viruses using nucleic acid sequence-based amplification (NASBA)
    Lau, L. T.
    Fung, Y. W. W.
    Yu, A. C. H.
    [J]. NEW DIAGNOSTIC TECHNOLOGY: APPLICATIONS IN ANIMAL HEALTH AND BIOLOGICS CONTROLS, 2006, 126 : 7 - +
  • [7] Typing of Mycoplasma pneumoniae by nucleic acid sequence-based amplification, NASBA(R)
    Ovyn, C
    vanStrijp, D
    Leven, M
    Ursi, D
    vanGemen, B
    Goossens, H
    [J]. MOLECULAR AND CELLULAR PROBES, 1996, 10 (05) : 319 - 324
  • [8] ASYMMETRIC NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION (ASYMMETRIC-NASBA) : A DIFFERENT METHOD OF CONVENTIONAL NASBA
    Jia Huning
    Chen Zhiyao
    Wu Haiping
    Ye Hui
    Zhou Guohua
    [J]. PROGRESS ON POST-GENOME TECHNOLOGIES AND MODERN NATURAL PRODUCTS, 2011, 2011, : 253 - 255
  • [9] Nucleic acid sequence-based amplification (NASBA) detection of medically important Candida species
    Widjojoatmodjo, MN
    Borst, A
    Schukkink, RAF
    Box, ATA
    Tacken, NMM
    Van Gemen, B
    Verhoef, J
    Top, B
    Fluit, AC
    [J]. JOURNAL OF MICROBIOLOGICAL METHODS, 1999, 38 (1-2) : 81 - 90
  • [10] Using nucleic acid sequence-based amplification (NASBA) to detect enteroviral (EV) infection
    Malhotra, A
    Ginocchio, CC
    Barone, SR
    Krilov, LR
    Kaplan, MH
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1120 - 1120